MAOB and Parkinson disease: The conventional drugs for PD approved by the FDA are levodopa (L-DOPA), dopamine agonists, anticholinergics, catechol-O-methyltransferase (COMT) inhibitors, monoamine oxidase-B (MAO-B) inhibitors, and amantadine.